Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MorePfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MorePfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MoreModerna Inc. MRNA, -0.40% said Wednesday that it expects to resolve supply issues for its…
Read MoreModerna Inc. MRNA, -0.74% said Wednesday that it expects to resolve supply issues for its…
Read MoreU.S. known cases of COVID are continuing to ease and now stand at their lowest…
Read MoreThe news earlier this week that China and India plan to roll out nasal vaccines…
Read MoreThe Food and Drug Administration is expected to authorize new COVID-19 booster shots this week…
Read MoreSome 16 million Americans of working age have long-term COVID and as many as 4…
Read MorePfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in…
Read MoreFirst lady Jill Biden left isolation on Sunday, after testing negative for COVID twice and…
Read More